Cipta Sarana Medika Tbk. vs XL Axiata Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while XL Axiata Tbk. trades at Rp2,550 (market cap 46.05T, 3.6M 24h volume). The key difference: XL Axiata Tbk. is far larger — about 291.2× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 3.6M). Which is the better fit depends on your goals.
| DKHH | EXCL | |
|---|---|---|
Market Cap | 158.12B | 46.05T |
Volume | 8.21M | 3.6M |
Lot | 82.15K | 35.96K |
Turnover | 515.2M | 9.04B |
Average Price | 62.72 | 2,513.7 |
Value | 515.2M | 9.04B |
Indicative Equilibrium Price | 63 | 2,550 |
Indicative Equilibrium Volume | 1.33K | 977 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT XL Axiata Tbk (the Company) which was previously known as PT Excelcomindo Pratama Tbk, was initially established under the name PT Grahametropolitan Lestari. The Company was established on Oct 6th, 1989.The articles of association have been amended several times, most recently on Aug 2, 2005, concerning among other the change of par value, equity and public offering. The company started its operation since October 1996 and was the 3rd biggest company in Indonesia for the number of customer and income.
Read more on EXCL →